Home News DeepUll Obtains €13M in Series B Funding to Advance Its Platform for Early Sepsis Recognition

DeepUll Obtains €13M in Series B Funding to Advance Its Platform for Early Sepsis Recognition

DeepUll Obtains €13M in Series B Funding to Advance Its Platform for Early Sepsis Recognition

DeepUll, a medical diagnostics company developing culture-free, affordable diagnostic solutions for the early identification of sepsis and other acute infections, announces today that it has raised €13 million in a Series B financing round. The round was led by new investors Innvierte, part of the Spanish Ministry of Science and Innovation (CDTI), and an undisclosed strategic investor, as well as participation from existing investors Kurma Partners, Alta Life Sciences, UI Investissement (advised by Mérieux Equity Partners) and Axis Participaciones Empresariales.

DeepUll was founded in 2020 to create rapid, affordable, and accessible diagnostic solutions with a specific focus on culture-free diagnostics to enable sepsis recognition in pre-symptomatic patients. The company was founded by Jordi Carrera and Rafel Bru who previously co-founded STAT-Dx, which was acquired by Qiagen in 2018. The funds will be used to progress the development of DeepUll’s first-in-class sepsis recognition platform in the market.

Early sepsis recognition is vital in improving patient prognosis and reducing mortality. DeepUll’s technology aims to not only rapidly identify the causative infective agent(s) within a few hours, but will also provide phenotypic antimicrobial susceptibility results, reducing the unnecessary use of antimicrobials. The product will also utilize artificial intelligence to offer seamless medical decision support across all phases of patient management, from early disease recognition to precise diagnostics, up to therapy guidance.

Jordi Carrera, Chief Executive Officer and Co-Founder of DeepUll commented: “Early identification of sepsis is absolutely crucial to a patient’s prognosis, but the tools caregivers have available today are woefully inadequate. Our mission is to change this and this financing will allow us to ramp up our efforts to bring our first-in-class sepsis recognition platform to market. We are grateful to our existing investors and excited to welcome our new investors, which strengthens our investor base.”

Fiscal Stimulus Bolsters US Economic Growth in Q1, Fastest GDP Growth Since 2003

The second-fastest gross domestic product growth since the third quarter of 2003, reported by the Commerce Department on Thursday, left output just 0.9% shy of its level at the end of 2019.

US Economy Grew Robustly in First Quarter

GDP grew at a 6.4% annual rate in the quarter, leaving the economy within 1% of its peak.

Asia-Pacific Markets Broadly Lower As Investors Turn Cautious

Asia-Pacific markets struggled for gains Friday as investors turned cautious, despite a positive finish stateside in the previous session.

World Shares Near Record High on Strong US Economic Data and Earnings

US economic growth accelerated in the first quarter, fuelled by massive government aid.

How the US Won the Economic Recovery

I looked for a country that got the economic response to Covid-19 right. I found the US.

Barclays Boss Predicts Biggest Economic Boom Since 1948

The UK is about to experience its biggest economic boom since the aftermath of World War Two, according to Barclays boss Jes Staley. His upbeat...

Buying American Is Easier Said Than Done: Will Biden’s Plan Juice the US Economy?

Joe Biden and Donald Trump don't agree on much, but this much they do: We should buy American products. But that's easier said than done.

Silver Down As Dollar and Yields on Bonds Rose as US Economy Advanced

Benchmark U.S. 10-year Treasury yields hovered near a more than two-week high, increasing the opportunity cost of holding non-yielding bullion.

Yellen Doesn’t See Biden Plan Creating Inflation ‘Issue’

President Joe Biden’s economic plan is unlikely to create inflation pressure in the U.S. because the boost to demand will be spread over a decade, said Treasury Secretary Janet Yellen.

Inflationary Pressure, Hawkish Fed Official Remarks Keep US Stocks on Leash

Dow added 2.4%, the S&P 500 gained 5.6%, and the Nasdaq jumped 7%. Dow was down 0.54% at 33,875 while the S&P was down by 0.72%. Nasdaq was down by 0.85%.